Spectral Medical Inc T.EDT

Mercedesman

[ChesterLives]

Can you please explain the stats you provided in layman's terms?

Thanks

[mercedesman]

Briefly CL, as I understand it. Euphas2 an ongoing study of PMX in Italy (for the past 10 + years) is showing that for every 100 patients that received the current standard of care (no PMX filter), 75 would die (at a given level of infection/endotoxemia as measured by the SOFA score).    For those that received PMX in the Euphas 2 study, they died at the rate of 36 per 100.  

[ChesterLives]

Thanks Mercedesman, Looks to me like "exceeding expectations" is a vast understatement but I can see why they are being so conservative. I'd like to see some Eden data at some point as well. I am 100% confident that trial exceeding expectations as well.